Recon: J&J will reportedly seek authorization for boosters this week; Pfizer loses suit over copay assistance programs
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy